| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.27 | 1e-07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.24 | 0.0001 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |